Disorders of growth hormone and corticotropin regulation in patients with empty sella.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000238:Adenoma, Chromophobe / Q000175:diagnosis / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D001120:Arginine; D001786:Blood Glucose; D003397:Craniopharyngioma / Q000175:diagnosis / Q000503:physiopathology; D003937:Diagnosis, Differential; D005260:Female; D005947:Glucose; D005951:Glucose Tolerance Test; D006065:Gonadotropins, Pituitary / Q000652:urine; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007030:Hypothalamo-Hypophyseal System; D007328:Insulin; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D010902:Pituitary Gland / Q000503:physiopathology*; D010908:Pituitary Hormones, Anterior / Q000378:metabolism*; D010911:Pituitary Neoplasms / Q000175:diagnosis* / Q000503:physiopathology; D010913:Pituitary-Adrenal System; D012658:Sella Turcica / Q000002:abnormalities*; D013961:Thyroid Gland / Q000503:physiopathology; D014667:Vasopressins / Q000494:pharmacology
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D001786:Blood Glucose; D006065:Gonadotropins, Pituitary; D007328:Insulin; D010908:Pituitary Hormones, Anterior; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D001120:Arginine; D005947:Glucose; D008797:Metyrapone